These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19504371)

  • 1. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast.
    Friberg S; Rudén BI
    Acta Oncol; 2009; 48(6):822-31. PubMed ID: 19504371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer--a review.
    Gałecki J; Hicer-Grzenkowicz J; Grudzień-Kowalska M; Michalska T; Załucki W
    Acta Oncol; 2006; 45(3):280-4. PubMed ID: 16644570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
    Koukourakis MI; Yannakakis D
    Anticancer Res; 2001; 21(4B):2973-8. PubMed ID: 11712796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
    Forquer JA; Fakiris AJ; Timmerman RD; Lo SS; Perkins SM; McGarry RC; Johnstone PA
    Radiother Oncol; 2009 Dec; 93(3):408-13. PubMed ID: 19454366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.
    Appelt AL; Vogelius IR; Bentzen SM
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):147-52. PubMed ID: 22910644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison.
    Leborgne F; Fowler J
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1441-6. PubMed ID: 19395194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer.
    Chen AM; Hall WH; Li J; Beckett L; Farwell DG; Lau DH; Purdy JA
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):165-9. PubMed ID: 22444998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy.
    Wu SG; Huang SJ; Zhou J; Sun JY; Guo H; Li FY; Lin Q; Lin HX; He ZY
    Radiat Oncol; 2014 Dec; 9():292. PubMed ID: 25499205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients.
    Ortholan C; Hannoun-Lévi JM; Ferrero JM; Largillier R; Courdi A
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):154-62. PubMed ID: 15629606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
    Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
    Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
    Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.